Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Pfizer has ended its development of danuglipron, its oral weight-loss drug. (Image Credits: Reuters) Pfizer said on Monday it has discontinued development of experimental weight-loss pill ...

Ohio Attorney General Dave Yost issued a warning to several Ohio medical spas over their alleged claims regarding weight-loss drugs.According to Yost, more than a dozen medical spas in Ohio are ...

Iuliia Burmistrova/Getty Images GLP-1 drugs have helped people successfully achieve and maintain weight loss; however, losing muscle has been a significant concern. New research suggests that ...

WEIGHTWATCHERS CEO SIMA SISTANI OUT IN ABRUPT EXIT, EMBRACED WEIGHT LOSS DRUGS "While we are disappointed to discontinue the development of danuglipron, we remain committed to evaluating and ...

Recent findings presented at the European Congress on Obesity (ECO) in Malaga, Spain, reveal that the drug leads to significant and lasting weight loss over three years. This could change how ...

Eli Lilly, maker of Mounjaro, also offers another version of the drug called Zepbound, which is the same medication approved for weight loss, chronic weight management and sleep apnea. Other GLP-1 ...